Mydayis ER 25 MG capsule 100S
Ended Awarded
- Contract number
- SPE2DB25FTBLU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,298
Award facts
- Contract value 100% obligated
- $13,297.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,297.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mydayis ER 25 mg capsules (100-count units) on September 26, 2025, with an ultimate completion date of September 29, 2025. This non-set-aside competitive award was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mydayis is a prescription stimulant medication used to treat attention deficit hyperactivity disorder (ADHD), representing one of many pharmaceutical products the contractor supplies to federal military and healthcare systems.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its comprehensive DLA contract vehicle. The company's federal portfolio encompasses a diverse range of pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. The SPE2DX IDC serves as a global pharmaceutical support vehicle enabling flexible delivery of medical commodities to support military healthcare programs worldwide. This delivery order reflects continued utilization of the broader prime vendor contract to fulfill routine pharmaceutical supply needs for federal military medical operations.
Quick answers
Who was awarded contract SPE2DB25FTBLU?
SPE2DB25FTBLU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FTBLU worth?
The government has obligated $13,298 on SPE2DB25FTBLU.
Is contract SPE2DB25FTBLU an order under another contract?
Yes. SPE2DB25FTBLU is a delivery order under SPE2DB25D3202, an indefinite delivery contract.
Was contract SPE2DB25FTBLU competed?
The extent of competition for SPE2DB25FTBLU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award